Novavax Inc. Stock Outperforms Competitors On Strong Trading Day
I'm PortAI, I can summarize articles.
Novavax Inc. (NVAX) shares rose 2.30% to $6.68, outperforming competitors during a positive trading session. The NASDAQ Composite Index increased by 1.38% and the Dow Jones Industrial Average by 0.14%. Novavax's stock ended a two-day losing streak but remains 42.16% below its 52-week high. Competitors' performances varied: Johnson & Johnson fell 0.96%, Pfizer remained unchanged, and Merck & Co. rose 1.52%. Trading volume was slightly below the 50-day average.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Dow Jones The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments